Prelude Therapeutics
PRLD
#8532
Rank
โ‚ฌ0.23 B
Marketcap
2,94ย โ‚ฌ
Share price
-0.77%
Change (1 day)
103.06%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2026 (TTM): -0,80ย โ‚ฌ

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -0,86ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,18ย โ‚ฌ an increase over its 2024 EPS that were of -1,53ย โ‚ฌ.

EPS history for Prelude Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,80ย โ‚ฌ-31.6%
2025-1,18ย โ‚ฌ-23.21%
2024-1,53ย โ‚ฌ-16.83%
2023-1,84ย โ‚ฌ-17.21%
2022-2,22ย โ‚ฌ0.41%
2021-2,22ย โ‚ฌ-46.71%
2020-4,16ย โ‚ฌ435.92%
2019-0,78ย โ‚ฌ86.09%
2018-0,42ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 43.62%๐Ÿ‡บ๐Ÿ‡ธ USA